Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewCRBN-6-5-5-VHL is a potent and selective cereblon Degrader (PROTAC®) (DC50 = 1.5 nM). Induces complete degradation of cereblon in MM1S cells. Comprises a cereblon E3 ligase ligand joined by a linker to a ligand for the E3 ligase VHL. Cell-permeable.
CRBN antibody validated for Simple Western™ (automated Western) instruments and Western Blot also available: Catalog # NBP1-91810.
PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Application of CRBN-6-5-5-VHL in MM1S cells for CRBN-6-5-5-VHL. Western blot data showing potent knockdown of Cereblon (CRBN) mediated by the Degrader: CRBN-6-5-5-VHL in MM1S cells after 16 h incubation. IKZF1 (Ikaros) and IKZF3 (Aiolos) are transcription factors and neosubstrates of Cereblon. Application of CRBN-6-5-5-VHL does not result in degradation of these proteins. Pom; Pomalidomide. Data courtesy of Christian Steinebach, University of Bonn.
M. Wt | 972.21 |
Formula | C51H69N7O10S |
Storage | Store at -20°C |
Purity | ≥96% (HPLC) |
CAS Number | 2362575-45-7 |
Smiles | CC1=C(SC=N1)C2=CC=C(CNC([C@@H]3C[C@@H](O)CN3C([C@@H](NC(CCCCOCCCCCOCCCCCCNC4=CC=CC(C(N5C6CCC(NC6=O)=O)=O)=C4C5=O)=O)C(C)(C)C)=O)=O)C=C2 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 97.22 | 100 |
The following data is based on the product molecular weight 972.21. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.03 mL | 5.14 mL | 10.29 mL |
5 mM | 0.21 mL | 1.03 mL | 2.06 mL |
10 mM | 0.1 mL | 0.51 mL | 1.03 mL |
50 mM | 0.02 mL | 0.1 mL | 0.21 mL |
References are publications that support the biological activity of the product.
Steinebach et al (2019) PROTAC-mediated crosstalk between E3 ligases. Chem.Commun.(Camb) 55 1821 PMID: 30672516
If you know of a relevant reference for CRBN-6-5-5-VHL, please let us know.
Keywords: CRBN-6-5-5-VHL, CRBN-6-5-5-VHL supplier, PROTACs, proteolysis, targeting, chimeras, active, Degraders, degrades, VHL, von, Hippel, Lindau, Cereblon, CRBN, PROTAC, targeted, protein, degradation, tpd, Ubiquitin, E3, Ligases, Ligase, 6948, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for CRBN-6-5-5-VHL. Do you know of a great paper that uses CRBN-6-5-5-VHL from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review CRBN-6-5-5-VHL and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia